Company Filing History:
1 out of 1 
1 out of 1 
1 out of 33 
Years Active: 2016-2025
Title: Li Chen: Innovator in Biomedicine and Medicinal Chemistry
Introduction
Li Chen is a prominent inventor based in Suzhou, China, known for his significant contributions to the fields of biomedicine and medicinal chemistry. With a total of four patents to his name, he has made remarkable advancements in the development of antiviral drugs and vaccine components.
Latest Patents
One of Li Chen's latest patents focuses on mutants of respiratory syncytial virus (RSV) fusion proteins. This invention relates to an improved mutant that can form a trimeric structure without introducing a heterologous trimerization domain. The design includes mutations that stabilize the protein in its pre-fusion conformation, enhancing its immunogenicity when used as a vaccine component. This mutant can induce a high level of neutralizing antibodies, making it a promising candidate for RSV infection prevention and treatment.
Another notable patent involves a novel pyridone derivative, which is aimed at preventing or treating influenza type A and B viral infections. This compound acts as a cap-dependent endonuclease inhibitor, significantly inhibiting influenza endonuclease activity. The invention shows excellent clinical application prospects, as it can be used alone or in combination with other antiviral drugs to shorten the duration of influenza infections and reduce mortality rates.
Career Highlights
Li Chen has worked with reputable companies such as Jiangxi Caishi Pharmaceutical Technology Co., Ltd. and Ginkgo Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation in the pharmaceutical industry.
Collaborations
Li Chen has collaborated with notable coworkers, including Qing Shao and Xiaojian Xue, who have contributed to his research and development efforts in the field.
Conclusion
Li Chen's innovative work in biomedicine and medicinal chemistry has led to significant advancements in antiviral drug development and vaccine technology. His contributions are poised to make a lasting impact on public health and disease prevention.